Cefcore TZ 250mg/31.25mg Injection
Marketer
Biocore Pharmaceuticals
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Cefcore TZ 250mg/31.25mg Injection
Cefcore TZ Injection (250mg/31.25mg) is a dual-action antibiotic indicated for a range of bacterial infections. Its mechanism combats microbial proliferation, thereby controlling infection spread. Administration must always be overseen by a qualified medical practitioner. Strict adherence to the prescribed dosage schedule is crucial; complete the entire course, regardless of symptom improvement. Premature cessation can compromise its effectiveness. Potential side effects include, but are not limited to, gastrointestinal upset (nausea, vomiting, diarrhea). Seek immediate medical attention if any adverse reactions worsen. Allergic reactions (skin rashes, itching, swelling, respiratory distress) necessitate prompt medical care. Inform your physician of all current medications, including over-the-counter drugs, before commencing treatment. This is especially important for pregnant or lactating individuals. Alcohol consumption should be avoided due to the risk of increased drowsiness. While typically non-impairing, avoid driving if drowsiness or dizziness occurs. Rest, proper nutrition, and hydration are essential for optimal recovery. Your doctor may order blood tests and other diagnostic procedures to monitor treatment efficacy.
Primary Ingredients of Cefcore TZ 250mg/31.25mg Injection
No information provided. Please provide the text you wish me to rephrase.
Uses of Cefcore TZ 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Cefcore TZ 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider; please do not self-medicate.
Common Side effects of Cefcore TZ 250mg/31.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Cefcore TZ 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Cefcore TZ 250mg/31.25mg Injection works:
Ceftriaxone and Tazobactum, combined as Cefcore TZ 250mg/31.25mg Injection, offer a dual-action approach to bacterial infection. Ceftriaxone, a crucial antibiotic component, disrupts bacterial cell wall synthesis, thereby inhibiting bacterial growth and survival. Tazobactum, a beta-lactamase inhibitor, counters bacterial resistance mechanisms, optimizing Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Concurrent use of alcohol and Cefcore TZ 250mg/31.25mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
Cefcore TZ 250mg/31.25mg Injection is typically deemed safe for use in pregnancy. Preclinical trials in animals revealed minimal or no harmful consequences for the fetus; nevertheless, data from human trials are scarce.
Breast feedingCAUTION
The administration of Cefcore TZ 250mg/31.25mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's course of treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
The administration of Cefcore TZ 250mg/31.25mg Injection can induce drowsiness, blurred vision, and dizziness. Refrain from operating a vehicle should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Cefcore TZ 250mg/31.25mg Injection to individuals with renal impairment. Physician consultation is recommended.
LiverCAUTION
The injectable formulation of Cefcore TZ (250mg/31.25mg) requires careful administration in individuals with significant hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Dosage alteration for Cefcore TZ (250mg/31.25mg) injection is unnecessary for patients exhibiting mild or moderately compromised liver function.
What if you forget to take Cefcore TZ 250mg/31.25mg Injection :
Omitting a scheduled dose of Cefcore TZ 250mg/31.25mg Injection necessitates contacting your physician.
Facts to Know About Cefcore TZ 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently